Skip to content

Urine Levels of Metanephrin and Normetanephrin in Patients With Frequent Ventricular Premature Complex

Urine Levels of Metanephrin and Normetanephrin in Patients With Frequent Ventricular Premature Complex

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03447002
Enrollment
100
Registered
2018-02-27
Start date
2018-02-15
Completion date
2019-09-30
Last updated
2019-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ventricular Contraction

Keywords

premature, pvc

Brief summary

Enhanced automaticity process is the underlying mechanism for arrhythmias due to excess catecholamines. Catecholamines may increase in patients with PVC. Metabolites of catecholamines are metanephrine and normetanephrine. Our aim is to measure 24 hours urine levels of metanephrine and normetanephrine.

Detailed description

Premature ventricular complex is a very frequent arrhythmia. Suggested mechanisms for PVCs are reentry, triggered activity, and enhanced automaticity. Enhanced automaticity process is the underlying mechanism for arrhythmias due to excess catecholamines. Catecholamines may increase in patients with PVC. Half-lives of catecholamines are very short and rather changeable. Therefore, 24 hours urine levels of catecholamines are the more sensitive than plasma levels. Metabolites of catecholamines are metanephrine and normetanephrine. Our aim is to measure 24 hours urine levels of metanephrine and normetanephrine.

Interventions

DIAGNOSTIC_TEST24 hours urine levels metanephrine and normetanephrine

24 hours rhythm recording and 24 hours urine measurement

Sponsors

TC Erciyes University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

* PVC's rate is more than % 5 in 24 hours rhythm recording

Exclusion criteria

* ischemic heart disease * hyperthyroidism * patients with low ejection fraction

Design outcomes

Primary

MeasureTime frameDescription
metanephrine and normetanephrine levelsabout 10 monthsmetanephrine and normetanephrine levels asociated premature ventricular complex frequents

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026